With 81% of Americans owning smartphones, people are more likely to use them reliably than provisioned devices. It makes sense to incorporate personal devices into clinical trials wherever feasible.
This article was written by Jonathan Andrus, Chief Business Officer, at Clinical Ink to appear in the May 2021 issue of Clinical Researcher, the official journal of the Association of Clinical Research Professionals.
